SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC)
- Spyros A. Charonis
- , Lisa M. James
- , Apostolos P. Georgopoulos
Research output: Contribution to journal › Article › peer-review
12
Link opens in a new tab
Scopus
citations